Company Information & Drug Savings for Neurocrine Biosciences, Inc. Medications
Neurocrine Biosciences is a biopharmaceutical company focused on neurological and endocrine disorders. Based in San Diego, the company developed Ingrezza (valbenazine), the first FDA-approved treatment for tardive dyskinesia, and Elagolix-based products Orilissa and Oriahnn for endometriosis and uterine fibroids. Neurocrine’s research targets movement disorders, psychiatric conditions, and hormone-related diseases.
How to Contact Neurocrine Biosciences, Inc.
Phone
1-858-617-7600Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
Experienced a Side Effect?
Report to Yellow Card (UK) or MedWatch (US)
